N

Minerva Neurosciences
D

NERV

1.50000
USD
0.01
(0.67%)
مغلق
حجم التداول
0
الربح لكل سهم
-3
العائد الربحي
-
P/E
2
حجم السوق
10,490,109
أصول ذات صلة
A
ANVS
-0.06000
(-2.94%)
1.98000 USD
C
CRVS
0.02000
(0.57%)
3.50000 USD
C
CYCC
-0.01000
(-0.69%)
1.44000 USD
M
MGTX
0.07000
(1.39%)
5.11000 USD
NTRA
NTRA
0.850
(0.56%)
153.310 USD
X
XNCR
-0.12000
(-1.56%)
7.57000 USD
المزيد
الأخبار المقالات

العنوان: Minerva Neurosciences

القطاع: Healthcare
الصناعة: Biotechnology
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.